Do you have any sources you can share on the compassionate use results that utilize both Yervoy and PV10?I think
- The compassionate use program has not used the Yervoy/PV-10 combination;
- PV-10 has been successfully utilized in the program after Yervoy failed a patient;
- There is a positive view (how much, widespread and/or consensus-based I cannot say with certainty) in the melanoma community that PV-10 would improve Yervoy to the benefit of patients requiring such a combination; and
- Moffitt has not yet conducted murine study work on the combination, but think they want to do such work at some point.